🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.01
-0.18 (-1.77%)
Nov 19, 2026, 4:00 PM EST - Market closed

Corvus Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15.014.588.7412.6213.1663.46
Short-Term Investments
187.9352.1743.2214.5329.145.99
Cash & Short-Term Investments
202.9556.7551.9627.1542.369.45
Cash Growth
208.95%9.21%91.40%-35.82%-39.09%56.92%
Accounts Receivable
0.010.040.080.030.590.51
Other Receivables
1.280.340.140.040.050.03
Receivables
1.290.370.220.060.630.54
Prepaid Expenses
0.330.170.470.380.430.45
Other Current Assets
1.790.921.760.370.290.87
Total Current Assets
206.3558.2154.4127.9643.6671.31
Property, Plant & Equipment
1.361.061.331.392.573.64
Long-Term Investments
14.4710.9912.5416.1221.8834.27
Other Long-Term Assets
1.70.860.630.090.130.24
Total Assets
223.8871.1268.9145.5568.24109.46

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.652.492.581.531.981.57
Accrued Expenses
8.916.253.443.737.396.96
Current Portion of Leases
0.490.40.191.371.231.05
Other Current Liabilities
0.370.2429.20.250.160.12
Total Current Liabilities
15.429.3835.46.8710.759.69
Long-Term Leases
0.140.530.94-1.372.6
Total Liabilities
15.569.9136.346.8712.1312.29

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
674.19474.39430.86374.36364.36361.67
Retained Earnings
-464.29-412.29-397.01-334.72-307.69-266.38
Comprehensive Income & Other
-1.59-0.9-1.29-0.97-0.561.87
Total Common Equity
208.3261.2132.5738.6856.1297.16
Shareholders' Equity
208.3261.2132.5738.6856.1297.16
Total Liabilities & Equity
223.8871.1268.9145.5568.24109.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.630.941.121.372.63.65
Net Cash (Debt)
202.3155.8150.8425.7839.765.8
Net Cash Growth
212.80%9.78%97.25%-35.08%-39.67%56.87%
Net Cash Per Share
2.260.700.830.540.851.57
Filing Date Shares Outstanding
84.3583.9968.1449.0446.5746.55
Total Common Shares Outstanding
84.3274.767.949.0446.5546.55
Working Capital
190.9348.8319.0121.0932.9161.62
Book Value Per Share
2.470.820.480.791.212.09
Tangible Book Value
208.3261.2132.5738.6856.1297.16
Tangible Book Value Per Share
2.470.820.480.791.212.09
Machinery
3.242.842.692.852.822.62
Leasehold Improvements
0.370.032.082.082.082.08
SEC Filings: 10-K · 10-Q